Version in force , Modified +607 −0§
Amended by Regulation (EU) 2026/1165 32026R1165 on EUR-Lex (external, EUR-Lex)
dates added to the text: 2018-06-07, 2026-01-01, 2026-06-15, 2030-12-31
Explanation, written by a model and checked against the cited text
Paragraph 5 now adds a further derogation stating that data protection periods for active substance/product-type combinations lacking an approval decision under Article 89(1), third subparagraph, by 7 June 2018 will end on 31 December 2030.
A new provision also allows data owners to claim compensation for access to their data for the period from 1 January 2026 to 15 June 2026 from a substance or product supplier that benefitted from the absence of protection and was included in the list under paragraph 1 during that period.
Cited: Art. 95, v2 (external, EUR-Lex)
v1 is the previous version, v2 this one.
Text from EUR-Lex, before and after
Previous version, in force 11 June 2024 02012R0528-20240611 → this version, in force 15 June 2026 02012R0528-20260615
Article 95 Transitional measures concerning access to the active substance dossier 1. As of 1 September 2013, the Agency shall make publicly available and shall regularly update a list of all active substances, and all substances generating an active substance, for which … 534 unchanged words … periods for active substance/product-type combinations listed in Annex II to Regulation (EC) No 1451/2007, but for which a decision on inclusion in Annex I to Directive 98/8/EC was not taken before 1 September 2013, shall end on 31 December 2025. By way of derogation from the first subparagraph of this paragraph, all data protection periods for active substance/product-type combinations for which a decision on the approval has not been adopted in accordance with Article 89(1), third subparagraph, by 7 June 2018, shall end on 31 December 2030. Data owners may claim compensation for access to their data for the period from 1 January 2026 to 15 June 2026 from a substance supplier or product supplier having benefitted from the absence of protection and having been included in the list referred to in paragraph 1 of this Article during that period. 6. Paragraphs 1 to 5 shall not apply to substances listed in Annex I in categories 1 to 5 and category 7 or to biocidal products containing only such substances. 7. The Agency shall regularly update the list referred to in paragraph 1 of this Article. Following the renewal of the approval of an active substance, the Agency shall remove from the list any substance supplier or product supplier who has not, within 12 months of the renewal, submitted all the relevant data or a letter of access to all the relevant data, either in accordance with the second subparagraph of paragraph 1 of this Article or in an application in accordance with Article 13.